These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12644732)

  • 1. Flupenthixol in relapse prevention in schizophrenics with comorbid alcoholism: results from an open clinical study.
    Soyka M; Aichmüller C; v Bardeleben U; Beneke M; Glaser T; Hornung-Knobel S; Wegner U
    Eur Addict Res; 2003 Apr; 9(2):65-72. PubMed ID: 12644732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment with flupenthixol decanoate of a patient with both schizophrenia and alcoholism.
    Soyka M; Sand P
    Pharmacopsychiatry; 1995 Mar; 28(2):64-5. PubMed ID: 7624388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuation ECT in treatment-resistant schizophrenia: a controlled study.
    Chanpattana W; Chakrabhand ML; Sackeim HA; Kitaroonchai W; Kongsakon R; Techakasem P; Buppanharun W; Tuntirungsee Y; Kirdcharoen N
    J ECT; 1999 Sep; 15(3):178-92. PubMed ID: 10492856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].
    Wobrock T; D'Amelio R; Falkai P
    Nervenarzt; 2008 Jan; 79(1):17-8, 20-2, 24-6 passim. PubMed ID: 17619840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential attrition rates in alcohol abusing and nonabusing schizophrenic inpatients: a methodological note.
    Searles JS; Alterman AI
    Alcohol Clin Exp Res; 1992 Aug; 16(4):705-7. PubMed ID: 1530133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flupenthixol as a potential pharmacotreatment of alcohol and cocaine abuse/dependence.
    Soyka M; De Vry J
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):325-32. PubMed ID: 10974602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
    Soni SD; Sampath G; Shah A; Krska J
    Acta Psychiatr Scand; 1992 May; 85(5):354-9. PubMed ID: 1351333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations.
    Wobrock T; Soyka M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1375-85. PubMed ID: 18394768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study.
    Levin FR; Evans SM; Coomaraswammy S; Collins ED; Regent N; Kleber HD
    Am J Drug Alcohol Abuse; 1998 Aug; 24(3):343-60. PubMed ID: 9741939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia.
    Chanpattana W; Chakrabhand ML; Kongsakon R; Techakasem P; Buppanharun W
    J ECT; 1999 Jun; 15(2):129-39. PubMed ID: 10378152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
    San L; Arranz B; Martinez-Raga J
    Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance use among schizophrenic outpatients: prevalence, course, and relation to functional status.
    Chouljian TL; Shumway M; Balancio E; Dwyer EV; Surber R; Jacobs M
    Ann Clin Psychiatry; 1995 Mar; 7(1):19-24. PubMed ID: 8541933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alcohol consumption and its significance in therapeutic residences for psychiatric patients].
    Bullenkamp J; Voges B
    Psychiatr Prax; 1994 Sep; 21(5):179-83. PubMed ID: 7972559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of alcoholism on the prognosis of schizophrenic patients.
    Kozarić-Kovacić D; Folnegović-Smalc V; Folnegović Z; Maruĭć A
    J Stud Alcohol; 1995 Nov; 56(6):622-7. PubMed ID: 8558893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?
    Kalyoncu A; Mirsal H; Pektas O; Unsalan N; Tan D; Beyazyürek M
    J Psychopharmacol; 2005 May; 19(3):301-5. PubMed ID: 15888516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Schizophrenia and substance dependence].
    Uchtenhagen A
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(5):215-23. PubMed ID: 8658102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Consumption patterns and motivation for use of addictive drugs in schizophrenic patients].
    Lambert M; Haasen C; Mass R; Krausz M
    Psychiatr Prax; 1997 Jul; 24(4):185-9. PubMed ID: 9340658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyskinesia and withdrawal from alcohol.
    Halliday J
    Br J Psychiatry; 1994 Sep; 165(3):409-10. PubMed ID: 7994523
    [No Abstract]   [Full Text] [Related]  

  • 19. Flupenthixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study.
    Wiesbeck GA; Weijers HG; Lesch OM; Glaser T; Toennes PJ; Boening J
    Alcohol Alcohol; 2001; 36(4):329-34. PubMed ID: 11468134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alcohol dependence comorbidity and antipsychotic medication on volumes of the thalamus and pons in schizophrenia.
    Sullivan EV; Rosenbloom MJ; Serventi KL; Deshmukh A; Pfefferbaum A
    Am J Psychiatry; 2003 Jun; 160(6):1110-6. PubMed ID: 12777269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.